Steward Partners Investment Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.64M | Buy |
128,288
+13,760
| +12% | +$917K | 0.04% | 389 |
|
|
2026
Q1 | $7.19M | Buy |
114,528
+9,650
| +9% | +$672K | 0.04% | 410 |
|
|
2025
Q4 | $6.96M | Buy |
104,878
+29,239
| +39% | +$1.89M | 0.04% | 391 |
|
|
2025
Q3 | $5.09M | Sell |
75,639
-1,076
| -1% | -$85.2K | 0.03% | 465 |
|
|
2025
Q2 | $6.7M | Buy |
76,715
+6,294
| +9% | +$493K | 0.05% | 353 |
|
|
2025
Q1 | $4.81M | Buy |
70,421
+24,461
| +53% | +$2M | 0.04% | 410 |
|
|
2024
Q4 | $3.57M | Sell |
45,960
-2,417
| -5% | -$179K | 0.03% | 466 |
|
|
2024
Q3 | $3.24M | Sell |
48,377
-15,577
| -24% | -$1.28M | 0.03% | 490 |
|
|
2024
Q2 | $7.25M | Buy |
63,954
+12,217
| +24% | +$1.54M | 0.08% | 258 |
|
|
2024
Q1 | $7.18M | Buy |
51,737
+46,519
| +892% | +$5.85M | 0.08% | 259 |
|
|
2023
Q4 | $648K | Buy |
5,218
+2,299
| +79% | +$235K | 0.01% | 882 |
|
|
2023
Q3 | $272K | Sell |
2,919
-22,561
| -89% | -$2.54M | ﹤0.01% | 1155 |
|
|
2023
Q2 | $3.27M | Buy |
25,480
+21,977
| +627% | +$2.66M | 0.05% | 350 |
|
|
2023
Q1 | $407K | Sell |
3,503
-404
| -10% | -$45.2K | 0.01% | 1005 |
|
|
2022
Q4 | $442K | Sell |
3,907
-489
| -11% | -$53.7K | 0.01% | 953 |
|
|
2022
Q3 | $354K | Sell |
4,396
-464
| -10% | -$39.3K | 0.01% | 977 |
|
|
2022
Q2 | $362K | Sell |
4,860
-940
| -16% | -$85.8K | 0.01% | 960 |
|
|
2022
Q1 | $742K | Buy |
5,800
+36
| +0.6% | +$3.94K | 0.01% | 790 |
|
|
2021
Q4 | $774K | Buy |
5,764
+940
| +19% | +$135K | 0.01% | 782 |
|
|
2021
Q3 | $660K | Buy |
4,824
+188
| +4% | +$23.7K | 0.01% | 819 |
|
|
2021
Q2 | $495K | Buy |
4,636
+168
| +4% | +$16.1K | 0.01% | 937 |
|
|
2021
Q1 | $401K | Buy |
4,468
+3,436
| +333% | +$323K | 0.01% | 970 |
|
|
2020
Q4 | $95K | Buy |
1,032
+464
| +82% | +$41.4K | ﹤0.01% | 1385 |
|
|
2020
Q3 | $59K | Sell |
568
-552
| -49% | -$57.7K | ﹤0.01% | 1425 |
|
|
2020
Q2 | $114K | Buy |
1,120
+400
| +56% | +$35.8K | ﹤0.01% | 1097 |
|
|
2020
Q1 | $48K | Sell |
720
-400
| -36% | -$24.9K | ﹤0.01% | 1277 |
|
|
2019
Q4 | $61K | Hold |
1,120
| – | – | ﹤0.01% | 1313 |
|
|
2019
Q3 | $41K | Buy |
1,120
+280
| +33% | +$10.9K | ﹤0.01% | 1433 |
|
|
2019
Q2 | $31K | Buy |
+840
| New | +$26.4K | ﹤0.01% | 1529 |
|
|
2018
Q4 | – | Sell |
-80
| Closed | -$3K | – | 1109 |
|
|
2018
Q3 | $3K | Buy |
+80
| New | +$2.48K | ﹤0.01% | 2271 |
|
|
2018
Q1 | – | Sell |
-72
| Closed | -$1K | – | 2240 |
|
|
2017
Q4 | $1K | Hold |
72
| – | – | ﹤0.01% | 1771 |
|
|
2017
Q3 | $0 | Sell |
72
-572
| -89% | -$10.1K | ﹤0.01% | 1692 |
|
|
2017
Q2 | $11K | Hold |
644
| – | – | ﹤0.01% | 1018 |
|
|
2017
Q1 | $13K | Buy |
+644
| New | +$12.6K | ﹤0.01% | 865 |
|
Other funds holding DXCM
Steward Partners Investment Advisory's DXCM Position: Q2 2026 in Review
Steward Partners Investment Advisory increased its DexCom (DXCM) stake by 12% in Q2 2026, buying an estimated $917K and bringing the position to 128,288 shares worth $8.64M. The position accounts for 0.04% of the portfolio, ranked #389.
Steward Partners Investment Advisory first reported a position in DXCM in Q1 2017 and has held it in 34 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Steward Partners Investment Advisory held 128,288 shares of DexCom worth $8.64M as of Q2 2026.
- Steward Partners Investment Advisory bought 13,760 DexCom shares in Q2 2026, an estimated $917K.
- DexCom made up 0.04% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #389 holding.
- Steward Partners Investment Advisory first reported a position in DexCom in Q1 2017 and has held it in 34 quarters since.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.